Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Bechtel Exits TerraPower's Sodium-Cooled Reactor Project
U.S. engineering, procurement, construction (EPC) and project management company Bechtel has decided to withdraw from TerraPower's Natrium nuclear reactor project. TerraPower stated that both parties have decided to develop independently and will re-tender the project's engineering, procurement and construction contract for building the first Natrium nuclear reactor in Kemmerer, Wyoming, USA.
2026-09-23
Mochovce Nuclear Power Plant Unit 4 Officially Connected to the Grid
2026-09-23
Framatome of France Secures First U.S. High-Assay Low-Enriched Uranium Nuclear Fuel Contract
2026-09-23
Samsung C&T Teams Up with GE, Hitachi and Synthos to Enter Europe's Small Modular Reactor Market
2026-09-23
Palisades Nuclear Power Plant Restart Suspended Due to Fuel Assembly Issue
2026-09-23
Kairos Power Secures $100 Million Investment from Samsung to Build Nuclear Reactors for Google
2026-09-23
Weilan Stellar Completes China's First Stellarator Magnet Cryogenic Comprehensive Test Platform in Three Months, First Round of Magnet Testing Launched
2026-09-23
Turkey's National Nuclear Energy Agency (TUNAS) and the U.S. Trade and Development Agency (USTDA) Launch New Nuclear Energy Cooperation
2026-09-23
Vietnam Holds Scientific Seminar on "Developing Nuclear Energy for Green Growth and National Energy Security"
2026-09-22
On September 21, in order to further promote the construction of a quality control system for domestic radiotherapy equipment, standardize clinical quality control work for Tomo equipment, and facilitate multi-party collaborative development among industry, academia, research, and medical institutions, CNNC High Energy organized a seminar on quality control standardization for radiotherapy equipment. The meeting brought together industry forces from multiple sectors. Professor Zhang Fuquan, President of the Radiotherapy Equipment Technology Branch of the China Association of Medical Equipment and of Peking Union Medical College Hospital, and Professor Qiu Jie, Vice President of the Radiotherapy Equipment Technology Branch of the China Association of Medical Equipment and of Peking Union Medical College Hospital, attended the meeting as clinical experts; management, technical, and business representatives from CNNC High Energy, CNNC Accuray, Shuimu Medical, Shuimu Lingrui, and other units attended the meeting together. At the meeting, with...
2026-09-22
From September 9 to 11, 2026, the 26th Asia-Oceania Congress of Medical Physics (AOCMP 2026) was held at the Busan Port International Exhibition & Convention Center (BPEX) in South Korea. Hosted by the Korean Society of Medical Physics (KSMP), this year's congress focused on innovative applications of cutting-edge technologies such as artificial intelligence and automation in the field of medical physics, and is a highly influential academic event in the Asia-Pacific region. Wang Xiaomin, Deputy General Manager of Guoke Ion, and Yang Wenjie, Assistant to the General Manager, led a delegation to attend the congress, actively carrying out academic exchanges and industry engagement. During the congress, the Guoke Ion team conducted technical presentations and exchanges through specialized seminars and a corporate exhibition booth. At the specialized seminar, the team systematically introduced the company's ion therapy equipment and its self-developed...
2026-09-22
On September 21, China General Nuclear Power Group Co., Ltd. and the People's Government of Sichuan Province signed a strategic cooperation agreement in Chengdu. Wang Xiaohui, Secretary of the Sichuan Provincial Party Committee and Director of the Standing Committee of the Sichuan Provincial People's Congress, Shi Xiaolin, Deputy Secretary of the Provincial Party Committee and Governor, held a working meeting with Yang Changli, Secretary of the Party Committee and Chairman of China General Nuclear Power Group Co., Ltd., and Pang Songtao, Deputy Secretary of the Party Committee and General Manager, and together witnessed the signing of the agreement. During the meeting, the two sides, focusing on implementing General Secretary Xi Jinping's important instructions on Sichuan's work and the decisions and arrangements of the Party Central Committee, exchanged views on deepening strategic cooperation during the 15th Five-Year Plan period, further optimizing the investment layout in Sichuan, promoting clean energy development and construction, strengthening the high-end energy equipment manufacturing industry, and advancing...
2026-09-22
Jiluntai Company, a nuclear medicine innovation enterprise invested and incubated by Baiyang Pharmaceutical Group, has recently made important progress. Its independently developed Class 1 chemical radioactive diagnostic new drug —— Technetium [⁹⁹ᵐTc] hydrazinonicotinamide dual-chain Ark peptide injection (⁹⁹ᵐTc‑HP‑Ark2), has received supplementary clinical trial application approval from the National Medical Products Administration (NMPA), which means the product will continue to undergo clinical trials, bringing new hope for precision subtyping and treatment of breast cancer. This product is a radioactive diagnostic agent for SPECT/CT imaging, intended for the differential diagnosis of HER2-positive breast cancer. HER2 is an important prognostic indicator for malignant tumors such as breast cancer...
2026-09-21
Following its political commitments to the "Code of Conduct on the Safety and Security of Radioactive Sources" and the "Guidance on the Import and Export of Radioactive Sources," China has made a commitment to the International Atomic Energy Agency (IAEA) to comply with the "Management of Disused Radioactive Sources Guidelines" (hereinafter referred to as the "Disused Sources Guidelines"), marking a further improvement of China's international benchmarking system for the full chain and entire process of radioactive source management. The relevant information was officially published on the IAEA website on September 9. The "Disused Sources Guidelines" is one of the two important supporting guidance documents of the IAEA's "Code of Conduct on the Safety and Security of Radioactive Sources," approved and issued by the Board of Governors in 2017. As an internationally applicable non-binding normative framework, the Guidelines provide a unified reference standard for the standardized management of disused radioactive sources by member states, covering key areas such as policy planning, legislative development, regulatory responsibilities, storage and transport, full-process control, and international cooperation, and identifying multiple management pathways including return to supplier, recycling and reuse, long-term storage, and safe disposal, adapting to the nuclear technology utilization development levels and regulatory systems of different countries.
2026-09-20
The North China Regional Office of Nuclear and Radiation Safety Supervision of the Ministry of Ecology and Environment is committed to enhancing the level of nuclear safety control and has innovatively built a risk-informed supervision system. Through the implementation of a risk grading list, it promotes differentiated and targeted supervision, thereby advancing safety control and effectively improving supervision efficiency. By comprehensively identifying risk points in the design and manufacturing activities of Class 1E electrical equipment, the North China Regional Office has established the "Class 1E Electrical Equipment Supervision Risk Grading List." This list classifies risk hazards into four levels and establishes a closed-loop supervision mechanism featuring pre-event warning, in-process tracking, and post-event review. This enables supervision intensity to be dynamically adjusted according to risk levels, ensuring...
2026-09-18
Microstructure Imaging's software platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The platform is designed to enhance neurological positron emission tomography (PET) images using structural magnetic resonance imaging (MRI). The software, called MICSI-PET, can denoise and super-resolve PET images using MRI guidance while preserving quantitative PET information. It supports PET exams for amyloid, Tau, and FDG (fluorodeoxyglucose), and can provide automated Centiloid measurements for amyloid imaging and CenTauR measurements for Tau imaging....
2026-09-18
